$ICUI
ICU Medical Inc

2011 Q2 Form 10-Q Financial Statement

#000088398411000071 Filed on July 22, 2011

View on sec.gov

Income Statement

Concept 2011 Q2 2010 Q2
Revenue $77.80M $68.63M
YoY Change 13.36% 28.51%
Cost Of Revenue $41.60M $36.74M
YoY Change 13.23% 33.1%
Gross Profit $36.20M $31.89M
YoY Change 13.52% 23.6%
Gross Profit Margin 46.53% 46.47%
Selling, General & Admin $19.73M $19.37M
YoY Change 1.85% 17.41%
% of Gross Profit 54.5% 60.75%
Research & Development $2.491M $952.0K
YoY Change 161.66% 58.67%
% of Gross Profit 6.88% 2.99%
Depreciation & Amortization $4.600M $4.000M
YoY Change 15.0% 8.11%
% of Gross Profit 12.71% 12.54%
Operating Expenses $22.22M $20.32M
YoY Change 9.33% 18.85%
Operating Profit $13.98M $11.80M
YoY Change 18.44% 35.67%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $431.0K $63.00K
YoY Change 584.13% -79.0%
Pretax Income $14.41M $11.87M
YoY Change 21.45% 31.84%
Income Tax $4.918M $4.153M
% Of Pretax Income 34.13% 35.0%
Net Earnings $9.493M $7.566M
YoY Change 25.47% 32.74%
Net Earnings / Revenue 12.2% 11.03%
Basic Earnings Per Share $0.69 $0.56
Diluted Earnings Per Share $0.67 $0.55
COMMON SHARES
Basic Shares Outstanding 13.85M shares 13.47M shares
Diluted Shares Outstanding 14.26M shares 13.66M shares

Balance Sheet

Concept 2011 Q2 2010 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $120.8M $83.10M
YoY Change 45.37% -42.57%
Cash & Equivalents $87.37M $57.60M
Short-Term Investments $33.40M $25.50M
Other Short-Term Assets $12.40M $10.60M
YoY Change 16.98% 19.1%
Inventory $49.37M $41.20M
Prepaid Expenses
Receivables $51.79M $48.70M
Other Receivables $4.500M $800.0K
Total Short-Term Assets $238.9M $184.3M
YoY Change 29.61% -10.62%
LONG-TERM ASSETS
Property, Plant & Equipment $87.56M $80.50M
YoY Change 8.77% 14.18%
Goodwill $1.478M
YoY Change
Intangibles $13.78M
YoY Change
Long-Term Investments
YoY Change
Other Assets $4.600M $3.700M
YoY Change 24.32% -24.49%
Total Long-Term Assets $107.5M $102.4M
YoY Change 4.94% 10.23%
TOTAL ASSETS
Total Short-Term Assets $238.9M $184.3M
Total Long-Term Assets $107.5M $102.4M
Total Assets $346.3M $286.7M
YoY Change 20.8% -4.15%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $12.31M $17.50M
YoY Change -29.67% 82.29%
Accrued Expenses $14.47M $13.70M
YoY Change 5.63% 22.32%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $26.78M $31.30M
YoY Change -14.44% 50.48%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $4.500M $4.800M
YoY Change -6.25% 9.09%
Total Long-Term Liabilities $4.500M $4.800M
YoY Change -6.25% 9.09%
TOTAL LIABILITIES
Total Short-Term Liabilities $26.78M $31.30M
Total Long-Term Liabilities $4.500M $4.800M
Total Liabilities $39.20M $41.80M
YoY Change -6.22% 36.6%
SHAREHOLDERS EQUITY
Retained Earnings $276.4M
YoY Change
Common Stock $57.86M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $31.13M
YoY Change
Treasury Stock Shares 892.0K shares
Shareholders Equity $307.1M $244.9M
YoY Change
Total Liabilities & Shareholders Equity $346.3M $286.7M
YoY Change 20.8% -4.15%

Cashflow Statement

Concept 2011 Q2 2010 Q2
OPERATING ACTIVITIES
Net Income $9.493M $7.566M
YoY Change 25.47% 32.74%
Depreciation, Depletion And Amortization $4.600M $4.000M
YoY Change 15.0% 8.11%
Cash From Operating Activities $10.30M $7.300M
YoY Change 41.1% -8.75%
INVESTING ACTIVITIES
Capital Expenditures -$4.900M -$900.0K
YoY Change 444.44% -81.25%
Acquisitions
YoY Change
Other Investing Activities $4.600M $16.20M
YoY Change -71.6% -270.53%
Cash From Investing Activities -$100.0K $15.30M
YoY Change -100.65% -208.51%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 6.000M -4.500M
YoY Change -233.33% -4600.0%
NET CHANGE
Cash From Operating Activities 10.30M 7.300M
Cash From Investing Activities -100.0K 15.30M
Cash From Financing Activities 6.000M -4.500M
Net Change In Cash 16.20M 18.10M
YoY Change -10.5% -401.67%
FREE CASH FLOW
Cash From Operating Activities $10.30M $7.300M
Capital Expenditures -$4.900M -$900.0K
Free Cash Flow $15.20M $8.200M
YoY Change 85.37% -35.94%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
6354000 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0 USD
CY2011Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
12308000 USD
CY2010Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
10879000 USD
CY2011Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
51789000 USD
CY2010Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
55106000 USD
CY2010Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
14629000 USD
CY2011Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
14471000 USD
CY2011Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
93233000 USD
CY2010Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
86052000 USD
CY2011Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
4012000 USD
CY2010Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1064000 USD
CY2011Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
56377000 USD
CY2010Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
56502000 USD
CY2011Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1232000 USD
CY2010Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
742000 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
145000 shares
CY2011Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
748000 shares
CY2010Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
922000 shares
CY2011Q2 us-gaap Assets
Assets
346329000 USD
CY2010Q4 us-gaap Assets
Assets
312226000 USD
CY2010Q4 us-gaap Assets Current
AssetsCurrent
207833000 USD
CY2011Q2 us-gaap Assets Current
AssetsCurrent
238875000 USD
CY2011Q2 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
33444000 USD
CY2010Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
14507000 USD
CY2010 us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
0 USD
us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
0 USD
CY2010Q4 us-gaap Availableforsale Securities Gross Unrealized Gain
AvailableforsaleSecuritiesGrossUnrealizedGain
0 USD
CY2011Q2 us-gaap Availableforsale Securities Gross Unrealized Gain
AvailableforsaleSecuritiesGrossUnrealizedGain
0 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
354000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
262000 USD
CY2011Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
87368000 USD
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
78850000 USD
CY2011Q2 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
120812000 USD
CY2009Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
51248000 USD
CY2010Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
57602000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
8518000 USD
CY2010Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
93357000 USD
CY2011Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2010Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2011Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.1
CY2010Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.1
CY2011Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2010Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2011Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14855000 shares
CY2010Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14855000 shares
CY2010Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13659000 shares
CY2011Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13963000 shares
CY2010Q4 us-gaap Common Stock Value
CommonStockValue
1486000 USD
CY2011Q2 us-gaap Common Stock Value
CommonStockValue
1486000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
22642000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
5954000 USD
CY2010Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
3206000 USD
CY2011Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
10700000 USD
CY2010Q4 us-gaap Convertible Preferred Stock Nonredeemable Or Redeemable Issuer Option Value
ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue
0 USD
CY2011Q2 us-gaap Convertible Preferred Stock Nonredeemable Or Redeemable Issuer Option Value
ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue
0 USD
CY2011Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
41595000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
74171000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
78440000 USD
CY2010Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
36735000 USD
CY2011Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
0 USD
CY2010Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
254000 USD
CY2011Q2 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
4991000 USD
CY2010Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
4564000 USD
CY2011Q2 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
4635000 USD
CY2011Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
7974000 USD
CY2010Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
8023000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9052000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8602000 USD
CY2010Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
5053000 USD
us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div style="font-family:Times New Roman;font-size:10pt;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">New Accounting Pronouncements:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2011, the Financial Accounting Standards Board issued Accounting Standards Update No.&#160;2011-05 for Comprehensive Income (Topic 220):&#160; &#8220;Presentation of Comprehensive Income&#8221;.&#160; This Update improves the comparability, consistency and transparency of financial reporting and increases the prominence of items reported in other comprehensive income. This Update eliminates the option to present the components of other comprehensive income as part of the statement of changes in stockholder's equity, which is how the Company presented such components in its Annual Report on Form 10-K for the year ended December 31, 2010. This Update is effective for interim and annual periods beginning after December 15, 2011 and is not expected to have a material effect on our results of operations, but will change the presentation of our financial statements. &#160; </font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"></br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2011, the Financial Accounting Standards Board issued Accounting Standards Update No.&#160;2011-04 for Fair Value Measurement (Topic 820):&#160; &#8220;Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. GAAP and IFRSs&#8221;.&#160; This Update addresses how to measure fair value and requires new disclosures about fair value measurements. The amendments in this Update are effective for interim and annual periods beginning after December 15, 2011. &#160; </font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"></br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In January&#160;2010, the Financial Accounting Standards Board issued Accounting Standards Update No.&#160;2010-06 for Fair Value Measurements and Disclosures (Topic 820):&#160; &#8220;Improving Disclosures about Fair Value Measurements&#8221;.&#160; This Update requires new disclosures for transfers in and out of Level 1 and 2 and activity in Level 3.&#160; This Update also clarifies existing disclosures for level of disaggregation and about inputs and valuation techniques.&#160; The new disclosures are effective for interim and annual periods beginning after December&#160;15, 2009, except for the Level 3 disclosures, which are effective for fiscal years beginning after December&#160;15, 2010 and for interim periods within those years.&#160; The Company had no Level 3 investments in the fiscal year beginning after December&#160;15, 2010, and was therefore not impacted by this new pronouncement in the three and six months ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">June&#160;30, 2011</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div>
CY2011Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.69
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.88
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.28
CY2010Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.57
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.24
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.86
CY2010Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.56
CY2011Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.67
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
1167000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-3521000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.35
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.35
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
2717000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
58000 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Other Comprehensive Income
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncome
0 USD
CY2010Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Other Comprehensive Income
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncome
0 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease
0 USD
CY2011Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease
0 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
150000 USD
CY2010Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
150000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
834000 USD
CY2010Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
750000 USD
CY2010Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0 USD
CY2009Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
900000 USD
CY2010Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
900000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
56000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-49000 USD
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
2500000 USD
CY2010Q4 us-gaap Goodwill
Goodwill
1478000 USD
CY2011Q2 us-gaap Goodwill
Goodwill
1478000 USD
us-gaap Gross Profit
GrossProfit
70827000 USD
CY2010Q2 us-gaap Gross Profit
GrossProfit
32127000 USD
us-gaap Gross Profit
GrossProfit
59054000 USD
CY2011Q2 us-gaap Gross Profit
GrossProfit
36201000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
18412000 USD
CY2011Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
14411000 USD
CY2010Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
11866000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
27025000 USD
CY2010Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4153000 USD
CY2011Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4918000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9459000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6444000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1286000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1140000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1970000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3908000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-599000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1387000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-254000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-2283000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1423000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4025000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1784000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1373000 USD
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
223000 shares
CY2010Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
188000 shares
CY2011Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
405000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
394000 shares
CY2011Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
13780000 USD
CY2010Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
14806000 USD
CY2011Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
18878000 USD
CY2010Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
17445000 USD
CY2011Q2 us-gaap Inventory Net
InventoryNet
49372000 USD
CY2010Q4 us-gaap Inventory Net
InventoryNet
44056000 USD
CY2010Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
22805000 USD
CY2011Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
26270000 USD
CY2010Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
3806000 USD
CY2011Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
4224000 USD
us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
947000 USD
us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
399000 USD
us-gaap Legal Fees
LegalFees
0 USD
CY2011Q2 us-gaap Legal Fees
LegalFees
0 USD
us-gaap Legal Fees
LegalFees
-2500000 USD
CY2010Q2 us-gaap Legal Fees
LegalFees
0 USD
CY2011Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
346329000 USD
CY2010Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
312226000 USD
CY2011Q2 us-gaap Liabilities Current
LiabilitiesCurrent
26779000 USD
CY2010Q4 us-gaap Liabilities Current
LiabilitiesCurrent
25762000 USD
CY2010Q4 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
4155000 USD
CY2011Q2 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
4471000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8198000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-27740000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-26310000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
20076000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
25463000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
17539000 USD
CY2011Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
431000 USD
CY2010Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
63000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
255000 USD
CY2011Q2 us-gaap Operating Expenses
OperatingExpenses
22221000 USD
CY2010Q2 us-gaap Operating Expenses
OperatingExpenses
20324000 USD
us-gaap Operating Expenses
OperatingExpenses
44636000 USD
us-gaap Operating Expenses
OperatingExpenses
40897000 USD
CY2010Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
11803000 USD
CY2011Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
13980000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
18157000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
26191000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Period Increase Decrease
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease
6014000 USD
CY2010Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Period Increase Decrease
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease
4507000 USD
CY2011Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Period Increase Decrease
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease
-1207000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Period Increase Decrease
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease
-5076000 USD
us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
129000 USD
us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
956000 USD
CY2010Q2 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-154000 USD
CY2011Q2 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-47000 USD
CY2010Q2 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
152000 USD
us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
303000 USD
us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
268000 USD
CY2011Q2 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
135000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
28648000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
13698000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
32236000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11285000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9755000 USD
CY2011Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1
CY2010Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1
CY2010Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2011Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2010Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2011Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2011Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2010Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2011Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7443000 USD
CY2010Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9574000 USD
CY2011Q2 us-gaap Prepaid Taxes
PrepaidTaxes
4468000 USD
CY2010Q4 us-gaap Prepaid Taxes
PrepaidTaxes
687000 USD
us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
0 USD
us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
2781000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
44166000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
12900000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
893000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4572000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
103000 USD
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
747000 USD
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
909000 USD
CY2010Q2 us-gaap Profit Loss
ProfitLoss
7713000 USD
us-gaap Profit Loss
ProfitLoss
17566000 USD
us-gaap Profit Loss
ProfitLoss
11968000 USD
CY2011Q2 us-gaap Profit Loss
ProfitLoss
9493000 USD
CY2010Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
169597000 USD
CY2011Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
180794000 USD
CY2010Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
83545000 USD
CY2011Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
87561000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
97000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
437000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1870000 USD
CY2010Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
952000 USD
CY2011Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2491000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4543000 USD
CY2011Q2 us-gaap Restructuring Reserve
RestructuringReserve
300000 USD
CY2010Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
258790000 USD
CY2011Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
276356000 USD
CY2010Q2 us-gaap Revenues
Revenues
68862000 USD
us-gaap Revenues
Revenues
149267000 USD
us-gaap Revenues
Revenues
133225000 USD
CY2011Q2 us-gaap Revenues
Revenues
77796000 USD
CY2011Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
77661000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
148999000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
132922000 USD
CY2010Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
68710000 USD
CY2011Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
19730000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
42593000 USD
CY2010Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
19372000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
39027000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1979000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1668000 USD
CY2011Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
307105000 USD
CY2010Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
274286000 USD
CY2010Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
1196000 shares
CY2011Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
892000 shares
CY2011Q2 us-gaap Treasury Stock Value
TreasuryStockValue
31126000 USD
CY2010Q4 us-gaap Treasury Stock Value
TreasuryStockValue
41428000 USD
CY2011Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14257000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14166000 shares
CY2010Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13657000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13888000 shares
CY2010Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13469000 shares
CY2011Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13852000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13665000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13772000 shares
icui Debt Securities Callable Period
DebtSecuritiesCallablePeriod
1Y
icui Debt Securities Maturity Date Range High
DebtSecuritiesMaturityDateRangeHigh
2037
icui Debt Securities Maturity Date Range Low
DebtSecuritiesMaturityDateRangeLow
2011
icui Increase Decrease In Prepaid And Deferred Income Taxes
IncreaseDecreaseInPrepaidAndDeferredIncomeTaxes
-2857000 USD
icui Increase Decrease In Prepaid And Deferred Income Taxes
IncreaseDecreaseInPrepaidAndDeferredIncomeTaxes
1421000 USD
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2011
dei Document Period End Date
DocumentPeriodEndDate
2011-06-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000883984
CY2011Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
13967817 shares
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
ICU MEDICAL INC/DE

Files In Submission

Name View Source Status
0000883984-11-000071-index-headers.html Edgar Link pending
0000883984-11-000071-index.html Edgar Link pending
0000883984-11-000071.txt Edgar Link pending
0000883984-11-000071-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
icui-20110630.xml Edgar Link completed
icui-20110630.xsd Edgar Link pending
icui-20110630_cal.xml Edgar Link unprocessable
icui-20110630_def.xml Edgar Link unprocessable
icui-20110630_lab.xml Edgar Link unprocessable
icui-20110630_pre.xml Edgar Link unprocessable
icui-ex311_20110630x10q.htm Edgar Link pending
icui-ex312_2011063010xq.htm Edgar Link pending
icui-ex321_20110630x10q.htm Edgar Link pending
icui0630201110-q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending